TD Cowen Trims Molina Healthcare (NYSE:MOH) Target Price to $412.00

Molina Healthcare (NYSE:MOH) had its price target reduced by TD Cowen from $453.00 to $412.00 in a report released on Tuesday, Benzinga reports. TD Cowen currently has a buy rating on the stock.

A number of other equities research analysts also recently weighed in on MOH. Bank of America downgraded Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price objective on the stock. in a report on Thursday, March 28th. Barclays reduced their target price on Molina Healthcare from $437.00 to $430.00 and set an equal weight rating on the stock in a report on Thursday, April 25th. Stephens reaffirmed an equal weight rating and set a $390.00 price target on shares of Molina Healthcare in a report on Thursday, April 25th. Cantor Fitzgerald reissued an overweight rating and issued a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, April 4th. Finally, Wells Fargo & Company lowered their target price on Molina Healthcare from $410.00 to $375.00 and set an equal weight rating for the company in a research note on Monday, April 29th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Molina Healthcare currently has a consensus rating of Hold and an average target price of $398.55.

Molina Healthcare Stock Up 0.0 %

Shares of MOH stock opened at $339.68 on Tuesday. Molina Healthcare has a one year low of $266.35 and a one year high of $423.92. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a fifty day moving average price of $384.15 and a 200 day moving average price of $371.76. The stock has a market cap of $19.91 billion, a P/E ratio of 18.43, a price-to-earnings-growth ratio of 1.04 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The company had revenue of $9.93 billion during the quarter, compared to analysts’ expectations of $9.45 billion. During the same quarter in the prior year, the company posted $5.81 EPS. The business’s revenue was up 21.9% on a year-over-year basis. Analysts predict that Molina Healthcare will post 23.59 earnings per share for the current year.

Insider Activity

In related news, Director Richard M. Schapiro sold 711 shares of Molina Healthcare stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the transaction, the director now owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the transaction, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The disclosure for this sale can be found here. Insiders have sold 16,711 shares of company stock valued at $6,472,517 over the last 90 days. 1.10% of the stock is owned by company insiders.

Institutional Trading of Molina Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in Molina Healthcare in the third quarter worth $30,000. McIlrath & Eck LLC bought a new stake in shares of Molina Healthcare in the 4th quarter valued at $34,000. VisionPoint Advisory Group LLC raised its stake in Molina Healthcare by 105.6% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after buying an additional 57 shares during the period. Raleigh Capital Management Inc. lifted its holdings in Molina Healthcare by 40.4% during the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after acquiring an additional 36 shares in the last quarter. Finally, Principal Securities Inc. acquired a new position in Molina Healthcare in the fourth quarter valued at about $42,000. 98.50% of the stock is owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.